ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
106,355.70
2.30%
S&P 500
6,094.91
-0.39%
Dow Jones
44,396.57
-0.38%
US Dollar vs Yen
155.8745
-0.18%
Brent Oil
77.715
0.50%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. HCW Biologics Inc (HCWB) 銘柄情報

HCW Biologics Inc

HCW Biologics Inc (HCWB)

NASDAQ
0.35051
0.00241
( 0.69% )
更新日時： 04:06:47
15分遅延

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
0.35051
買値
0.3432
売値
0.3511
出来高
49,572
0.3329 日の範囲 0.36
0.2721 52 週間の範囲 2.52
時価総額
13.257M
前日終値
0.3481
始値
0.341
時刻
3
@
0.353
最終取引時間
04:04:25
財務取引量
US$ 17,224
VWAP
0.347454
平均取引量 (3 か月)
10,790,900
発行済株式数
37,823,394
配当利回り
-
PER
-0.53
1 株当たり利益 (EPS)
-0.66
歳入
2.84M
純利益
-24.99M

HCW Biologics Inc について

HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a signi... HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.hcwbiologics.com
本社
Wilmington, Delaware, USA
設立
-
HCW Biologics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker HCWB. The last closing price for HCW Biologics was US$0.35. Over the last year, HCW Biologics shares have traded in a share price range of US$ 0.2721 to US$ 2.52.

HCW Biologics currently has 37,823,394 shares in issue. The market capitalisation of HCW Biologics is US$13.17 million. HCW Biologics has a price to earnings ratio (PE ratio) of -0.53.

HCWB 最新ニュース

その他のニュース

HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

MIRAMAR, Fla., Jan. 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and...

2025年1月15日
GlobeNewswire Inc.

Form 8-K - Current report

2024年12月23日
Edgar (US Regulatory)

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

Company Expected Notice for Continued Deficiency and Delist Letter from the Nasdaq Stock Market Company Intends to Request Hearing to Appeal in a Timely Manner MIRAMAR, Fla., Dec. 23, 2024...

2024年12月23日
GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities

2024年12月6日
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

2024年11月23日
Edgar (US Regulatory)

Form 8-K - Current report

2024年11月23日
Edgar (US Regulatory)

Form 8-K - Current report

2024年11月21日
Edgar (US Regulatory)

Form 424B2 - Prospectus [Rule 424(b)(2)]

2024年11月21日
Edgar (US Regulatory)

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

MIRAMAR, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and...

2024年11月19日
GlobeNewswire Inc.

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate

HCW Biologics entered into License, Research and Co-Development Agreement with WY Biotech for one of its new proprietary preclinical molecules HCW Biologics to receive upfront payment of $7...

2024年11月18日
GlobeNewswire Inc.
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.00349-0.9858757062150.3540.3877990.331024530.35326445CS
4-0.05899-14.40537240540.40950.4840.332130530.40673832CS
12-0.09649-21.58612975390.4472.520.2721107909001.19509497CS
26-0.24849-41.48414023370.5992.520.272147229921.19334499CS
52-0.76949-68.70446428571.122.520.272123894571.19332566CS
156-1.77949-83.54413145542.133.320.27218060711.20851387CS
260-7.14949-95.32653333337.57.510.27219163632.04535982CS

HCWB - Frequently Asked Questions (FAQ)

What is the current HCW Biologics share price?
The current share price of HCW Biologics is US$ 0.35051
How many HCW Biologics shares are in issue?
HCW Biologics has 37,823,394 shares in issue
What is the market cap of HCW Biologics?
The market capitalisation of HCW Biologics is USD 13.17M
What is the 1 year trading range for HCW Biologics share price?
HCW Biologics has traded in the range of US$ 0.2721 to US$ 2.52 during the past year
What is the PE ratio of HCW Biologics?
The price to earnings ratio of HCW Biologics is -0.53
What is the cash to sales ratio of HCW Biologics?
The cash to sales ratio of HCW Biologics is 4.66
What is the reporting currency for HCW Biologics?
HCW Biologics reports financial results in USD
What is the latest annual turnover for HCW Biologics?
The latest annual turnover of HCW Biologics is USD 2.84M
What is the latest annual profit for HCW Biologics?
The latest annual profit of HCW Biologics is USD -24.99M
What is the registered address of HCW Biologics?
The registered address for HCW Biologics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the HCW Biologics website address?
The website address for HCW Biologics is www.hcwbiologics.com
Which industry sector does HCW Biologics operate in?
HCW Biologics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NVNINVNI Group Ltd
US$ 4.815
(223.15%)
305.9M
CREVCarbon Revolution Public Ltd
US$ 7.71
(109.51%)
2.45M
GOEVCanoo Inc
US$ 0.6182
(87.33%)
253.52M
NEUPNeuphoria Therapeutics Inc
US$ 5.508
(57.82%)
23.01M
ACONAclarion Inc
US$ 0.0624
(44.44%)
702.61M
GODNUGolden Star Acquisition Corporation
US$ 3.60
(-72.01%)
4.53k
NXTTNext Technology Holding Inc
US$ 1.36
(-55.26%)
1.76M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
SGLYSingularity Future Technology Ltd
US$ 1.635
(-38.07%)
770.28k
GODNGolden Star Acquisition Corporation
US$ 5.55
(-34.97%)
44.12k
ACONAclarion Inc
US$ 0.0623
(44.21%)
702.62M
NVNINVNI Group Ltd
US$ 4.83
(224.16%)
305.93M
GOEVCanoo Inc
US$ 0.62
(87.88%)
253.53M
RIMEAlgorhythm Holdings Inc
US$ 0.0375
(9.97%)
240.45M
RGTIRigetti Computing Inc
US$ 13.8099
(2.52%)
174.77M

HCWB Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
HCWB
HCW Biologics
BIT
Q00423
Leonteq Securities
BIT
SENL5L
SG Issuer Societe Generale
BIT
F38964
Vontobel Financial Produ...
BIT
SL
Sanlorenzo
BIT
Q00452
Leonteq Securities
BIT
UC3F8S
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有